{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:07:02Z","timestamp":1778940422116,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T00:00:00Z","timestamp":1349136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1208\/s12248-012-9409-7","type":"journal-article","created":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T19:10:54Z","timestamp":1349118654000},"page":"15-29","source":"Crossref","is-referenced-by-count":12,"title":["Study Reanalysis Using a Mechanism-Based Pharmacokinetic\/Pharmacodynamic Model of Pramlintide in Subjects with Type 1 Diabetes"],"prefix":"10.1208","volume":"15","author":[{"given":"Jing","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia B.","family":"Landersdorfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda","family":"Cirincione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Jusko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,2]]},"reference":[{"issue":"3","key":"9409_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2337\/diaspect.17.3.183","volume":"17","author":"SL Aronoff","year":"2004","unstructured":"Aronoff SL, Berkowitz K, Shreiner B, Want L. Glucose metabolism and regulation: beyond insulin and glucagon. Diabetes Spectr. 2004;17(3):183\u201390.","journal-title":"Diabetes Spectr"},{"issue":"5","key":"9409_CR2","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1053\/meta.2002.32022","volume":"51","author":"MS Fineman","year":"2002","unstructured":"Fineman MS, Koda JE, Shen LZ, Strobel SA, Maggs DG, Weyer C, et al. The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes. Metab Clin Exp. 2002;51(5):636\u201341.","journal-title":"Metab Clin Exp"},{"issue":"1","key":"9409_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1210\/er.2006-0007","volume":"28","author":"J Gromada","year":"2007","unstructured":"Gromada J, Franklin I, Wollheim CB. Alpha-cells of the endocrine pancreas: 35\u00a0years of research but the enigma remains. Endocr Rev. 2007;28(1):84\u2013116.","journal-title":"Endocr Rev"},{"key":"9409_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1054-3589(05)52008-8","volume":"52","author":"A Young","year":"2005","unstructured":"Young A. Inhibition of glucagon secretion. Adv Pharmacol. 2005;52:151\u201371.","journal-title":"Adv Pharmacol"},{"issue":"27","key":"9409_CR5","doi-asserted-by":"publisher","first-page":"9516","DOI":"10.1021\/ja8097417","volume":"131","author":"F Evers","year":"2009","unstructured":"Evers F, Jeworrek C, Tiemeyer S, Weise K, Sellin D, Paulus M, et al. Elucidating the mechanism of lipid membrane-induced IAPP fibrillogenesis and its inhibition by the red wine compound resveratrol: a synchrotron X-ray reflectivity study. J Am Chem Soc. 2009;131(27):9516\u201321.","journal-title":"J Am Chem Soc"},{"issue":"15","key":"9409_CR6","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1111\/j.1742-4658.2006.05367.x","volume":"273","author":"B Konarkowska","year":"2006","unstructured":"Konarkowska B, Aitken JF, Kistler J, Zhang S, Cooper GJ. The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells. FEBS J. 2006;273(15):3614\u201324.","journal-title":"FEBS J"},{"issue":"4","key":"9409_CR7","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0022-2836(02)01377-3","volume":"326","author":"J Green","year":"2003","unstructured":"Green J, Goldsbury C, Mini T, Sunderji S, Frey P, Kistler J, et al. Full-length rat amylin forms fibrils following substitution of single residues from human amylin. J Mol Biol. 2003;326(4):1147\u201356.","journal-title":"J Mol Biol"},{"issue":"22","key":"9409_CR8","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.2146\/ajhp050341","volume":"62","author":"J McQueen","year":"2005","unstructured":"McQueen J. Pramlintide acetate. Am J Health Syst Pharm. 2005;62(22):2363\u201372.","journal-title":"Am J Health Syst Pharm"},{"issue":"5","key":"9409_CR9","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/ncpendmet0506","volume":"3","author":"SV Edelman","year":"2007","unstructured":"Edelman SV, Garg S, Kolterman OG. Is pramlintide a safe and effective adjunct therapy for patients with type 1 diabetes? Nat Clin Pract. 2007;3(5):E1. discussion E2.","journal-title":"Nat Clin Pract"},{"issue":"5","key":"9409_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3949\/ccjm.73.5.477","volume":"73","author":"BJ Hoogwerf","year":"2006","unstructured":"Hoogwerf BJ. Exenatide and pramlintide: new glucose-lowering agents for treating diabetes mellitus. Cleve Clin J Med. 2006;73(5):477\u201384.","journal-title":"Cleve Clin J Med"},{"issue":"3","key":"9409_CR11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jpeds.2009.03.012","volume":"155","author":"HP Chase","year":"2009","unstructured":"Chase HP, Lutz K, Pencek R, Zhang B, Porter L. Pramlintide lowered glucose excursions and was well-tolerated in adolescents with type 1 diabetes: results from a randomized, single-blind, placebo-controlled, crossover study. J Pediatr. 2009;155(3):369\u201373.","journal-title":"J Pediatr"},{"issue":"10","key":"9409_CR12","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.2337\/dc06-0042","volume":"29","author":"S Edelman","year":"2006","unstructured":"Edelman S, Garg S, Frias J, Maggs D, Wang Y, Zhang B, et al. A double-blind, placebo-controlled trial assessing pramlintide treatment in the setting of intensive insulin therapy in type 1 diabetes. Diabetes Care. 2006;29(10):2189\u201395.","journal-title":"Diabetes Care"},{"issue":"1","key":"9409_CR13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/j.1552-4604.1996.tb04147.x","volume":"36","author":"WA Colburn","year":"1996","unstructured":"Colburn WA, Gottlieb AB, Koda J, Kolterman OG. Pharmacokinetics and pharmacodynamics of AC137 (25,28,29 tripro-amylin, human) after intravenous bolus and infusion doses in patients with insulin-dependent diabetes. J Clin Pharmacol. 1996;36(1):13\u201324.","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"9409_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10928-007-9078-9","volume":"35","author":"W Byon","year":"2008","unstructured":"Byon W, Fletcher CV, Brundage RC. Impact of censoring data below an arbitrary quantification limit on structural model misspecification. J Pharmacokinet Pharmacodyn. 2008;35(1):101\u201316.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"5","key":"9409_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1023\/A:1012299115260","volume":"28","author":"SL Beal","year":"2001","unstructured":"Beal SL. Ways to fit a PK model with some data below the quantification limit. J Pharmacokinet Pharmacodyn. 2001;28(5):481\u2013504.","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"9409_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S1054-3589(05)52006-4","volume":"52","author":"A Young","year":"2005","unstructured":"Young A. Inhibition of gastric emptying. Adv Pharmacol. 2005;52:99\u2013121.","journal-title":"Adv Pharmacol"},{"issue":"12","key":"9409_CR17","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1136\/gut.24.12.1117","volume":"24","author":"PJ Collins","year":"1983","unstructured":"Collins PJ, Horowitz M, Cook DJ, Harding PE, Shearman DJ. Gastric emptying in normal subjects\u2014a reproducible technique using a single scintillation camera and computer system. Gut. 1983;24(12):1117\u201325.","journal-title":"Gut"},{"issue":"6","key":"9409_CR18","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/S0016-5085(84)80178-X","volume":"86","author":"H Minami","year":"1984","unstructured":"Minami H, McCallum RW. The physiology and pathophysiology of gastric emptying in humans. Gastroenterology. 1984;86(6):1592\u2013610.","journal-title":"Gastroenterology"},{"issue":"1","key":"9409_CR19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s001250050646","volume":"40","author":"MF Kong","year":"1997","unstructured":"Kong MF, King P, Macdonald IA, Stubbs TA, Perkins AC, Blackshaw PE, et al. Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM. Diabetologia. 1997;40(1):82\u20138.","journal-title":"Diabetologia"},{"issue":"9","key":"9409_CR20","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1177\/0091270007304457","volume":"47","author":"HE Silber","year":"2007","unstructured":"Silber HE, Jauslin PM, Frey N, Gieschke R, Simonsson US, Karlsson MO. An integrated model for glucose and insulin regulation in healthy volunteers and type 2 diabetic patients following intravenous glucose provocations. J Clin Pharmacol. 2007;47(9):1159\u201371.","journal-title":"J Clin Pharmacol"},{"issue":"10","key":"9409_CR21","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1177\/0091270007302168","volume":"47","author":"PM Jauslin","year":"2007","unstructured":"Jauslin PM, Silber HE, Frey N, Gieschke R, Simonsson US, Jorga K, et al. An integrated glucose-insulin model to describe oral glucose tolerance test data in type 2 diabetics. J Clin Pharmacol. 2007;47(10):1244\u201355.","journal-title":"J Clin Pharmacol"},{"issue":"12","key":"9409_CR22","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1109\/TBME.2006.883792","volume":"53","author":"C Dalla Man","year":"2006","unstructured":"Dalla Man C, Camilleri M, Cobelli C. A system model of oral glucose absorption: validation on gold standard data. IEEE Trans Biomed Eng. 2006;53(12):2472\u20138.","journal-title":"IEEE Trans Biomed Eng"},{"issue":"3","key":"9409_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/BF00400639","volume":"38","author":"S Dinneen","year":"1995","unstructured":"Dinneen S, Alzaid A, Turk D, Rizza R. Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM. Diabetologia. 1995;38(3):337\u201343.","journal-title":"Diabetologia"},{"key":"9409_CR24","unstructured":"Bea SB, Broeckmann AJ, Sheiner LB, Group NP. NONMEM users guides. San Francisco, CA: University of California; 2007."},{"issue":"2","key":"9409_CR25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1023\/A:1020561807903","volume":"26","author":"MO Karlsson","year":"1998","unstructured":"Karlsson MO, Jonsson EN, Wiltse CG, Wade JR. Assumption testing in population pharmacokinetic models: illustrated with an analysis of moxonidine data from congestive heart failure patients. J Pharmacokinet Biopharm. 1998;26(2):207\u201346.","journal-title":"J Pharmacokinet Biopharm"},{"issue":"2","key":"9409_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","volume":"13","author":"M Bergstrand","year":"2011","unstructured":"Bergstrand M, Hooker AC, Wallin JE, Karlsson MO. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J. 2011;13(2):143\u201351.","journal-title":"AAPS J"},{"issue":"5","key":"9409_CR27","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s001250050949","volume":"41","author":"MF Kong","year":"1998","unstructured":"Kong MF, Stubbs TA, King P, Macdonald IA, Lambourne JE, Blackshaw PE, et al. The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM. Diabetologia. 1998;41(5):577\u201383.","journal-title":"Diabetologia"},{"issue":"1","key":"9409_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.clpt.2004.03.006","volume":"76","author":"JJ Lima","year":"2004","unstructured":"Lima JJ, Matsushima N, Kissoon N, Wang J, Sylvester JE, Jusko WJ. Modeling the metabolic effects of terbutaline in beta2-adrenergic receptor diplotypes. Clin Pharmacol Ther. 2004;76(1):27\u201337.","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"9409_CR29","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/BF02980152","volume":"27","author":"SH Lee","year":"2004","unstructured":"Lee SH, Kwon KI. Pharmacokinetic-pharmacodynamic modeling for the relationship between glucose-lowering effect and plasma concentration of metformin in volunteers. Arch Pharm Res. 2004;27(7):806\u201310.","journal-title":"Arch Pharm Res"},{"issue":"6","key":"9409_CR30","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1006\/pupt.1999.0217","volume":"12","author":"K Gumbhir-Shah","year":"1999","unstructured":"Gumbhir-Shah K, Kellerman DJ, DeGraw S, Koch P, Jusko WJ. Pharmacokinetics and pharmacodynamics of cumulative single doses of inhaled salbutamol enantiomers in asthmatic subjects. Pulm Pharmacol Ther. 1999;12(6):353\u201362.","journal-title":"Pulm Pharmacol Ther"},{"issue":"1","key":"9409_CR31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0016-5085(83)80232-7","volume":"85","author":"W Brener","year":"1983","unstructured":"Brener W, Hendrix TR, McHugh PR. Regulation of the gastric emptying of glucose. Gastroenterology. 1983;85(1):76\u201382.","journal-title":"Gastroenterology"},{"issue":"9","key":"9409_CR32","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/BF00400362","volume":"36","author":"M Horowitz","year":"1993","unstructured":"Horowitz M, Edelbroek MA, Wishart JM, Straathof JW. Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia. 1993;36(9):857\u201362.","journal-title":"Diabetologia"},{"issue":"1","key":"9409_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0026-0495(97)90170-0","volume":"46","author":"BR Gedulin","year":"1997","unstructured":"Gedulin BR, Rink TJ, Young AA. Dose\u2013response for glucagonostatic effect of amylin in rats. Metab Clin Exp. 1997;46(1):67\u201370.","journal-title":"Metab Clin Exp"},{"issue":"1","key":"9409_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0016-5085(97)70080-5","volume":"113","author":"E Schvarcz","year":"1997","unstructured":"Schvarcz E, Palmer M, Aman J, Horowitz M, Stridsberg M, Berne C. Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus. Gastroenterology. 1997;113(1):60\u20136.","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"9409_CR35","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1002\/(SICI)1096-9136(199706)14:2+<S9::AID-DIA397>3.3.CO;2-4","volume":"14","author":"B Ludvik","year":"1997","unstructured":"Ludvik B, Kautzky-Willer A, Prager R, Thomaseth K, Pacini G. Amylin: history and overview. Diabet Med. 1997;14 Suppl 2:S9\u2013S13.","journal-title":"Diabet Med"},{"issue":"4","key":"9409_CR36","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.clinthera.2007.04.005","volume":"29","author":"D Singh-Franco","year":"2007","unstructured":"Singh-Franco D, Robles G, Gazze D. Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus. Clin Ther. 2007;29(4):535\u201362.","journal-title":"Clin Ther"},{"issue":"3","key":"9409_CR37","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1365-2125.2011.04109.x","volume":"73","author":"CB Landersdorfer","year":"2012","unstructured":"Landersdorfer CB, He YL, Jusko WJ. Mechanism-based population modelling of the effects of vildagliptin on GLP-1, glucose and insulin in patients with type 2 diabetes. Br J Clin Pharmacol. 2012;73(3):373\u201390.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"9409_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/gut.37.1.23","volume":"37","author":"TV Nowak","year":"1995","unstructured":"Nowak TV, Johnson CP, Kalbfleisch JH, Roza AM, Wood CM, Weisbruch JP, et al. Highly variable gastric emptying in patients with insulin dependent diabetes mellitus. Gut. 1995;37(1):23\u20139.","journal-title":"Gut"},{"issue":"1","key":"9409_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0026-0495(96)90192-4","volume":"45","author":"AA Young","year":"1996","unstructured":"Young AA, Gedulin BR, Rink TJ. Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7\u201336) NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake. Metab Clin Exp. 1996;45(1):1\u20133.","journal-title":"Metab Clin Exp"},{"issue":"10","key":"9409_CR40","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.clinthera.2005.10.009","volume":"27","author":"GJ Ryan","year":"2005","unstructured":"Ryan GJ, Jobe LJ, Martin R. Pramlintide in the treatment of type 1 and type 2 diabetes mellitus. Clin Ther. 2005;27(10):1500\u201312.","journal-title":"Clin Ther"},{"issue":"3","key":"9409_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2337\/diaclin.20.3.137","volume":"20","author":"JB Buse","year":"2002","unstructured":"Buse JB, Weyer C, Maggs DG. Amylin replacement with pramlintide in type 1 and type 2 diabetes: a physiological approach to overcome barriers with insulin therapy. Clin Diabetes. 2002;20(3):137\u201344.","journal-title":"Clin Diabetes"},{"issue":"9","key":"9409_CR42","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1055\/s-2002-34790","volume":"34","author":"M Fineman","year":"2002","unstructured":"Fineman M, Weyer C, Maggs DG, Strobel S, Kolterman OG. The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus. Horm Metab Res Hormon- und Stoffwechselforschung. 2002;34(9):504\u20138.","journal-title":"Horm Metab Res Hormon- und Stoffwechselforschung"},{"issue":"8","key":"9409_CR43","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1210\/jc.2007-0244","volume":"92","author":"S Porksen","year":"2007","unstructured":"Porksen S, Nielsen LB, Kaas A, Kocova M, Chiarelli F, Orskov C, et al. Meal-stimulated glucagon release is associated with postprandial blood glucose level and does not interfere with glycemic control in children and adolescents with new-onset type 1 diabetes. J Clin Endocrinol Metab. 2007;92(8):2910\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"9409_CR44","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2165\/00003088-200847070-00001","volume":"47","author":"CB Landersdorfer","year":"2008","unstructured":"Landersdorfer CB, Jusko WJ. Pharmacokinetic\/pharmacodynamic modelling in diabetes mellitus. Clin Pharmacokinet. 2008;47(7):417\u201348.","journal-title":"Clin Pharmacokinet"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-012-9409-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-012-9409-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-012-9409-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-012-9409-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T10:53:14Z","timestamp":1594723994000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-012-9409-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,2]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["9409"],"URL":"https:\/\/doi.org\/10.1208\/s12248-012-9409-7","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,2]]}}}